Healthcare -
Biotechnology - NASDAQ - US
$ 42.365
-1.29 %
$ 3.92 B
Market Cap
-6.74
P/E
RARE - CAPITAL EXPENDITURES
Capital Expenditures RARE - Ultragenyx Pharmaceutical Inc.
-7.49 M
LAST VALUE
77.36%
2 YEAR CAGR
21.31%
5 YEAR CAGR
-13.30%
10 YEAR CAGR